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Abstract. 
 
The mechanism of action of the oncogene 
 
bcl-2
 
, a key regulator of the apoptotic process, is still 
debated. We have employed organelle-targeted chime-
 
ras of the Ca
 
2
 
1
 
-sensitive photoprotein, aequorin, to in-
vestigate in detail the effect of Bcl-2 overexpression on 
intracellular Ca
 
2
 
1
 
 homeostasis. In the ER and the Golgi 
apparatus, Bcl-2 overexpression increases the Ca
 
2
 
1
 
 leak 
(while leaving Ca
 
2
 
1
 
 accumulation unaffected), hence 
reducing the steady-state [Ca
 
2
 
1
 
] levels. As a direct con-
sequence, the [Ca
 
2
 
1
 
] increases caused by inositol 1,4,5 
trisphosphate (IP3)-generating agonists were reduced 
in amplitude in both the cytosol and the mitochondria. 
Bcl-2 overexpression also reduced the rate of Ca
 
2
 
1
 
 in-
ﬂux activated by Ca
 
2
 
1
 
 store depletion, possibly by an 
adaptive downregulation of this pathway. By interfer-
ing with Ca
 
2
 
1
 
-dependent events at multiple intracellu-
lar sites, these effects of Bcl-2 on intracellular Ca
 
2
 
1
 
 ho-
meostasis may contribute to the protective role of this 
oncogene against programed cell death.
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Introduction
 
In the past years, Bcl-2, the mammalian homologue of
 
CED-9, the antiapoptotic gene initially described in 
 
Cae-
norhabditis elegans
 
, has emerged as a major checkpoint
controlling the escape of cells from their death fate (Kroe-
mer, 1997). In mammals, Bcl-2 is a member of a broad
family of related gene products, with various degrees of se-
quence identity and different functions. While Bcl-2 and
some members of the family (e.g., Bcl-x) protect the cells
from apoptosis, others (e.g., Bax) have the opposite effect.
However, while there is a general consensus on the role of
Bcl-2, its mechanism of action remains elusive. On one
hand, the various members of the family have been shown
to dimerize and to interact with cofactors of caspases, key
executors of the apoptotic machinery (Li and Yuan, 1999);
on the other, the specific localization of the protein on the
ER and outer mitochondrial membrane (Lithgow et al.,
1994) suggests that these proteins may interfere with some
specific functions localized in these organelles. In particu-
lar, Bcl-2 has been shown to prevent the release of cyto-
chrome c and AIF from mitochondria (Kluck et al., 1997;
Yang et al., 1997), events that are considered essential in
triggering apoptosis, whereas expression of Bax has oppo-
site effects (Jurgensmeier et al., 1998).
Among the various functions occurring on ER and mito-
chondrial membranes, ion fluxes are recognized to play
major roles. Thus, the intriguing possibility has emerged
that members of the Bcl-2 family affect the apoptotic pro-
cess by modulating ion fluxes in these organelles (Minn
et al., 1997; Schendel et al., 1998). In particular, recent
work in cell clones stably expressing the oncogene sug-
 
gests that Bcl-2 causes an overload of Ca
 
2
 
1
 
 within the ER
(Lam et al., 1994; He et al., 1997, Kuo et al., 1998). How-
ever, this effect appears in contrast with the observation
that Bcl-2 insertion in artificial lipid bilayers results in the
formation of ionic channels of low selectivity (Minn et al.,
1997). Such property should in fact cause a reduction in
the ER Ca
 
2
 
1
 
 content (due to an increased leak) rather
than excess accumulation. In this report, we have under-
taken a detailed investigation of Ca
 
2
 
1
 
 homeostasis at the 
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subcellular level using the recombinant aequorin (AEQ)
 
1
 
approach developed in our laboratory (Rizzuto et al.,
1992; De Giorgi et al., 1996). We conclude that Bcl-2 over-
expression affects Ca
 
2
 
1
 
 handling by reducing the state of
filling of the intracellular Ca
 
2
 
1
 
 stores. The implications of
these results for the protective action of Bcl-2 on apoptosis
are discussed.
 
Materials and Methods
 
Cell Culture and Transfection
 
HeLa cells were grown in DME supplemented with 10% FCS in 75-cm
 
2
 
Falcon flasks. Before transfection, cells were seeded onto 13-mm glass
coverslips and allowed to grow to 50% confluence. At this stage, transfec-
tion with 4 
 
m
 
g of DNA (3 
 
m
 
g Bcl-2 
 
1
 
 1 
 
m
 
g AEQ) was carried out as previ-
ously described (Rizzuto et al., 1995a) and AEQ measurements or immu-
nocytochemistry were performed 36 h after transfection. For fura-2
measurements, the cells were seeded onto 24-mm coverslips and transfec-
tion was carried out with 8 
 
m
 
g plasmid DNA (6 
 
m
 
g Bcl-2 
 
1
 
 2 
 
m
 
g mtGFP).
 
Aequorin Measurements
 
For cytosolic AEQ (cytAEQ) and mitochondrial AEQ (mtAEQ), the
coverslip with the cells was incubated with 5 
 
m
 
M coelenterazine for 1–2 h
in DME supplemented with 1% FCS, and then transferred to the perfu-
sion chamber. For reconstituting with high efficiency, the AEQ chimeras
targeted to the Golgi apparatus and the ER (GoAEQ and erAEQ, re-
spectively), the luminal [Ca
 
2
 
1
 
] of these compartments first must be re-
duced. This was obtained by incubating the cells for 1 h at 4
 
8
 
C in KRB
(Krebs-Ringer modified buffer: 125 mM NaCl, 5 mM KCl, 1 mM Na
 
3
 
PO
 
4
 
,
1 mM MgSO
 
4
 
,
 
 
 
5.5 mM glucose, and 20 mM Hepes, pH 7.4, at 37
 
8
 
C) sup-
plemented with coelenterazine 5 
 
m
 
M, the Ca
 
2
 
1
 
 ionophore ionomycin, and
600 
 
m
 
M EGTA. After this incubation, the cells were extensively washed
with KRB supplemented with 2% BSA and 1 mM EGTA, and then AEQ
reconstitution was carried out as described.
All AEQ measurements were carried out in KRB. Agonists and other
drugs were added to the same medium. In experiments with permeabi-
lized cells, a buffer mimicking the cytosolic ionic composition (intracellu-
lar buffer, IB: 140 mM KCl, 10 mM NaCl, 1 mM K
 
3
 
PO
 
4
 
, 5.5 mM glucose,
2 mM MgSO
 
4
 
, 1 mM ATP, 2 mM sodium succinate, 20 mM Hepes, pH
7.05, at 37
 
8
 
C) was employed. This solution was supplemented with either
100 
 
m
 
M EGTA or a fixed [Ca
 
2
 
1
 
] (buffered with 2 mM EGTA). The exper-
iments were terminated by lysing the cells with 100 
 
m
 
M digitonin in a hy-
potonic Ca
 
2
 
1
 
-rich solution (10 mM CaCl
 
2
 
 in H
 
2
 
O), thus discharging the re-
maining AEQ pool. The light signal was collected and calibrated into
[Ca
 
2
 
1
 
] values as previously described (Brini et al., 1995; Rizzuto et al.,
1995a). In brief, a 13-mm round coverslip with the transfected cells was
placed in a perfused, thermostated chamber located in the close proximity
of a low-noise photomultiplier, with built-in amplifier discriminator. The
output of the discriminator was captured by a Thorn-EMI photon count-
ing board and stored in an IBM-compatible computer for further analyses.
The AEQ luminescence data were calibrated off-line into [Ca
 
2
 
1
 
] values,
using a computer algorithm based on the Ca
 
2
 
1
 
 response curve of wild-type
and mutant AEQs, as previously described (Brini et al., 1995; Barrero et
al., 1997).
In some experiments using erAEQ, after reaching the plateau level, an
artifactual slow decrease in [Ca
 
2
 
1
 
] was observed. Such an artifact is due to
a small fraction of missorted AEQ in a low [Ca
 
2
 
1
 
] compartment and a
simple practical cure for it has been described by Maechler et al. (1999).
In the experiment of Fig. 4, cells transfected with erAEQ were used to
determine the steady [Ca
 
2
 
1
 
]
 
er 
 
obtained by incubating the cells in low Ca
 
2
 
1
 
medium. Two protocols were adopted that gave identical results. In the
first, cells incubated in normal medium were depleted according to the
 
standard protocol, but the Ca
 
2
 
1
 
 concentration during the refilling was re-
duced to 100 
 
m
 
M. In the second protocol, the cells were preincubated in
100 
 
m
 
M CaCl
 
2
 
 for 16 h, depleted, and finally refilled with an extracellular
Ca
 
2
 
1
 
 concentration of 100 
 
m
 
M.
 
Fura-2 Measurements
 
The coverslip with the cells was incubated with 5 
 
m
 
M fura-2 (added to
DME 
 
1
 
 1% FCS) at 37
 
8
 
C for 30 min, and after a brief washout was then
transferred to the thermostated stage of a Zeiss Axiovert inverted micro-
scope equipped with a Sutter filterwheel and 340/380 excitation filters.
The fluorescence data were collected with a Princeton Instruments back-
illuminated camera and expressed as emission ratios, using Metafluor soft-
ware (Universal Imaging). Within the microscope field, transfected and
untransfected cells were identified before carrying out the fura-2 moni-
toring by revealing mitochondrial-targeted green fluorescent protein
(mtGFP) fluorescence (excitation 480 nm, emission 510 nm).
 
Results and Discussion
 
To directly investigate the role of Bcl-2 in Ca
 
2
 
1
 
 homeosta-
sis, we have selectively measured the [Ca
 
2
 
1
 
] in different
cell compartments, i.e., the cytoplasm and the organelles
acting as sources (ER and Golgi apparatus) or targets (mi-
tochondria) of the Ca
 
2
 
1
 
 signal. Targeted AEQ chimeras
developed in our lab (Rizzuto et al., 1992; Brini et al.,
1995; Montero et al., 1995; Pinton et al., 1998) were em-
ployed. This approach has two major advantages. The first
is the high subcellular specificity of the probes, which al-
lows to clearly identify the effects of Bcl-2 expression on
the signaling properties of the various compartments; the
second is that the Ca
 
2
 
1
 
 probe can be cotransfected with
Bcl-2. We and others have previously shown that in tran-
sient cotransfection, the two recombinant proteins are ex-
pressed by the same subset of cells, thus avoiding the risks
associated with the use of stable clones or single cells
(Brini et al., 1995).
The effect of Bcl-2 expression on the cytosolic Ca
 
2
 
1
 
 sig-
nal elicited by an agonist, ATP, acting on receptors cou-
pled, through Gq proteins, to the production of inositol
1,4,5 trisphosphate (IP3) was first investigated. In the ex-
periment shown in Fig. 1, HeLa cells, either coexpressing
Bcl-2 and cytAEQ (Bcl-2–transfected) or expressing only
cytAEQ (controls) were challenged with ATP, which acts
on a Gq-coupled P2Y receptor. Both in control and Bcl-
2–transfected cells, ATP stimulation causes a rapid rise in
cytoplasmic Ca
 
2
 
1
 
 concentration ([Ca
 
2
 
1
 
]
 
c
 
), followed by a
gradually declining sustained plateau. In Bcl-2–transfected
cells, the [Ca
 
2
 
1
 
] increases evoked by stimulation with ATP
are significantly smaller than in controls (peak amplitude
1.53 
 
6
 
 0.22 vs. 2.06 
 
6
 
 0.13 
 
m
 
M,
 
 n 
 
5 
 
10; Fig. 1 A).
Since Bcl-2 is localized in the mitochondria also, and
thus could, at least in principle, enhance Ca
 
2
 
1
 
 uptake in
this organelle, a simple explanation for this result would
be that cytosolic Ca
 
2
 
1
 
 is more rapidly cleared by mito-
chondria, acting as an immobile buffer, placed in closed
proximity to IP3-gated channels. Fig. 1 B, however, shows
that this is not the case. Indeed, Bcl-2 overexpression does
not increase, but rather reduces, the mitochondrial [Ca
 
2
 
1
 
]
rise induced by ATP (peak amplitude 6.56 
 
6
 
 0.72 in con-
trols vs. 4.42 
 
6
 
 0.46 
 
m
 
M in Bcl-2–expressing cells;
 
 n 
 
5 
 
10).
Interestingly, the reduction caused by Bcl-2 overexpres-
sion appears larger in the mitochondria than in the cytosol,
both in absolute terms and as percent (26 vs. 33% reduc-
tion, respectively). While not responsible for the alteration
 
1
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of the cytosolic Ca
 
2
 
1
 
 signal, the effect of Bcl-2 on mito-
chondrial Ca
 
2
 
1
 
 homeostasis appears of major functional
relevance, given that key events occurring in the mito-
chondrial matrix, such as the stimulation of ATP produc-
tion (Jouaville et al., 1999) and possibly the opening of the
permeability transition pore, PTP (Bernardi, 1999), are
regulated by [Ca
 
2
 
1
 
]
 
m
 
.
A second possible explanation for the reduction in the
agonist-dependent [Ca
 
2
 
1
 
]
 
c
 
 (and [Ca
 
2
 
1
 
]
 
m
 
) increases was
next considered, i.e., a decrease in the amount of Ca
 
2
 
1
 
 re-
leased by the agonist-sensitive Ca
 
2
 
1
 
 stores. To investigate
this possibility, the [Ca
 
2
 
1
 
] in the lumen of the ER was
measured in cells cotransfected with Bcl-2 and an erAEQ
chimera (Montero et al., 1995). In addition, since we re-
cently have demonstrated that the Golgi apparatus shares
many of the Ca
 
2
 
1
 
 homeostatic properties of the ER (Pin-
ton et al., 1998), this latter organelle was also investigated.
Fig. 2 shows the calibrated [Ca
 
2
 
1
 
] values in the two com-
partments. To obtain reliable quantitative estimates of the
[Ca
 
2
 
1
 
] in the lumen of these two organelles, their [Ca21]
needs to be decreased during both the reconstitution of
AEQ with coelenterazine and the subsequent initial phase
of perfusion with KRB/EGTA in the luminometer (see
Materials and Methods). Under those conditions, the
[Ca21] was ,10 mM in both organelles. When the [Ca21] in
the perfusion medium was switched to 1 mM, the [Ca21] in
the lumen of the two compartments gradually increased,
reaching in control cells plateau values of 452 6 46 mM
(n 5 7) in the ER and 262 6 47 mM (n 5 7) in the Golgi
apparatus, respectively. In Bcl-2 transfected cells, lower
steady state values were attained in both compartments
(304 6 38 mM, n 5 7 for the ER, and 186 6 34 mM, n 5 7
for the Golgi apparatus, respectively). When the cells were
treated with ATP, rapid decreases in the [Ca21] of the two
compartments were observed, both in control and Bcl-
2–expressing cells. In both organelles, the decrease of
[Ca21] was larger and faster in controls compared with Bcl-
2–expressing cells, reflecting the higher filling state and
thus the more rapid flow through the IP3-gated channels.
The data reported above differ substantially from those
reported in WEHI7.2 clones, where Bcl-2 overexpression
results in an augmentation of the ER Ca21 content (Lam
et al., 1994; He et al., 1997). This discrepancy may be due
to the use of transient vs. stable transfections, in which the
results might reflect unique properties of the selected
clone and/or the long-term expression of a foreign gene
may result in adaptation phenomena that are only indi-
rect consequences of the expressed protein. This interpre-
tation might also explain the results obtained by Kuo and
coworkers in clones of MCF10A cells overexpressing
Figure 1 Cytoplasmic (A) and mitochondrial (B) Ca21 homeo-
stasis in control and Bcl-2–overexpressing HeLa cells. Parallel
batches of HeLa cells were either cotransfected with the appro-
priate AEQ chimera (cytAEQ and mtAEQ for monitoring the
cytoplasm and the mitochondria, respectively) and Bcl-2 (Bcl-2),
or transfected with the AEQ chimera alone (control). 36 h after
transfection, the measurement of AEQ luminescence was carried
out and calibrated into [Ca21] values, as described in Materials
and Methods. Where indicated, the cells, perfused with KRB,
were challenged with 100 mM ATP added to the same buffer.
These and the following traces are representative of ten experi-
ments that gave similar results.
Figure 2. Ca21 homeostasis in the lumen of the ER (A) and of
the Golgi apparatus (B) in control and Bcl-2–overexpressing
HeLa cells. Parallel batches of HeLa cells were either cotrans-
fected with the appropriate AEQ chimera (erAEQ and GoAEQ
for monitoring the lumen of the ER and of the Golgi apparatus,
respectively) and Bcl-2 (Bcl-2), or transfected with the AEQ chi-
mera alone (control). 36 h after transfection, the organelles were
depleted of Ca21 to optimize AEQ reconstitution. After reconsti-
tution, the cells were transferred to the luminometer chamber
and AEQ luminescence was collected and calibrated into [Ca21]
values. Where indicated, the cells were stimulated with 100 mM
ATP. All other conditions are as in Fig. 1.The Journal of Cell Biology, Volume 148, 2000 860
Bcl-2, in which an increase in SERCA2 (sarcoendoplasmic
reticulum Ca2+ ATPases 2) protein leads to accelerated
Ca21 uptake and enhanced Ca21 loading (Kuo et al.,
1998). On the other hand, it is possible that, although the
duration of these experiments is compatible with the time
course of the apoptotic process, the events observed in
transient experiments could include only some of the rele-
vant effects of Bcl-2 on the mechanisms controlling pro-
gramed cell death.
But how does Bcl-2 affect ER and Golgi Ca21 handling?
Given that the steady-state [Ca21] in both organelles de-
pends on the equilibrium between active accumulation
and passive leak, the effect of Bcl-2 could be on either pro-
cess. On one hand, Bcl-2 could reduce Ca21 uptake by the
SERCA, either by a direct effect on the pump or by reduc-
ing the resting cytosolic [Ca21]. On the other, it could in-
crease the passive diffusion of Ca21 from the ER. To clar-
ify this critical issue, we investigated these possibilities
independently.
At first, the possibility that Bcl-2 affected primarily cy-
tosolic [Ca21] (and hence [Ca21]er only indirectly) was
verified. Given that AEQ is not accurate enough to re-
veal small differences of [Ca21]  z1027 M, the resting
[Ca21]c was measured with the fluorescent indicator fura-2
(Grynkiewicz et al., 1985). In this experiment, to identify
Bcl-2–overexpressing cells in single-cell imaging experi-
ments, the cells were cotransfected with mitochondrially
targeted GFP, mtGFP(S65T) (Rizzuto et al., 1995b). GFP-
positive cells were distinguished from controls by the typi-
cal fluorescence emitted upon illumination with blue light.
No difference in the resting cytoplasmic [Ca21] between
Bcl-2–transfected and control cells was observed (data not
shown).
Then, we investigated whether Bcl-2 overexpression had
any direct effect on the activity of the SERCA pump. For
this purpose, the kinetics of Ca21 accumulation were stud-
ied in permeabilized cells (Fig. 3 A). After reconstituting
the photoprotein as in the experiment of Fig. 2, Bcl-2–trans-
fected and control cells were transferred to the lumi-
nometer chamber and perfused with a buffer (IB, see
Materials and Methods) mimicking intracellular ionic con-
ditions, supplemented with 100 mM EGTA (IB/EGTA).
After permeabilization with 100 mM digitonin added to
the same medium and wash in IB/EGTA, the medium was
switched to IB, containing 200 nM [Ca21] (IB/Ca21). Un-
der those conditions, [Ca21]er gradually increased, reach-
ing, in control cells, a plateau value of 728 6 60, n 5 5. In
Bcl-2–transfected cells, the maximal rate of Ca21 accumu-
lation was the same as in control cells (13 6 2 vs. 12 6 3
mM/s, n 5 5), arguing that the Ca21 pumping activity is not
modified. However, the steady-state value eventually at-
tained was distinctly lower (504 6 52 mM, n 5 5). There-
fore, these data exclude that the alteration of ER Ca21 ho-
meostasis is due to a reduction in the activity of the
SERCAs or to soluble cytosolic factors (that are released
into the medium after permeabilization with digitonin).
Rather, by demonstrating a difference only when ER re-
filling approaches the high [Ca21]er values of intact resting
cells, i.e., in conditions in which passive leak becomes sig-
nificant, they suggest that Bcl-2 acts on the latter process.
We sought direct evidence for this interpretation by
measuring the Ca21 leak rate from the ER of Bcl-2–express-
ing and control cells. After the depletion protocol, the
ER was first refilled by exposing the cells to extracellu-
lar [Ca21] ranging from 0.2–3 mM, thus resulting in differ-
ent levels of steady-state [Ca21]er. The SERCA blocker,
2,5-di-(tert-butyl)-1,4-benzohydroquinone (tBuBHQ), was
Figure 3. Kinetics of ER Ca21 uptake and release in control
and Bcl-2–transfected cells. A, ER Ca21 refilling in permeabi-
lized cells. Parallel batches of HeLa cells were either cotrans-
fected with erAEQmut and Bcl-2 (Bcl-2), or transfected with
erAEQmut alone (control). 36 h after transfection, depletion of
Ca21 stores and AEQ were carried out as in Fig. 2. The coverslip
with the cells was then transferred to the luminometer chamber.
The perfusion medium was changed to IB/EGTA, and permeabi-
lization was carried out by perfusing 100 mM digitonin (added to
the same medium) for 1 min. After a 2-min wash with IB/EGTA,
Ca21 accumulation in the ER was initiated by switching the me-
dium to IB containing a buffered Ca21 concentration of 0.2 mM
(see text for details). AEQ calibration was carried out as de-
scribed in Materials and Methods. B, Dependence on [Ca21]er of
the Ca21 leak rate from the ER. Transfection, depletion of Ca21
stores, and AEQ reconstitution were carried out as in A, then the
coverslip with the cells was transferred to the luminometer and
perfused with KRB/Ca21 until the steady-state [Ca21]er was
reached. Ca21 release was initiated by treating the cells with 50 mM
tBuBHQ. Based on the experimental trace, the maximal rates of
Ca21 release (measured from the first derivative) at different val-
ues of [Ca21]er were calculated and plotted for Bcl-2–transfected
and control cells. The plot contains data obtained from ten inde-
pendent experiments. In each experiment, duplicate samples of
control and Bcl-2–overexpressing cells were measured. Due to
the mixing time in the luminometer chamber, the kinetics of
[Ca21]er decrease are sigmoidal and the maximal rate is obtained
2–3 s after addition of tBuBHQ. Accordingly, we considered the
maximal rates the best approximation for the initial rate of
[Ca21]er decrease. The fitting of the curve shown in B was per-
formed using Microsoft Excel software.Pinton et al. Bcl-2 and Intracellular Ca21 Homeostasis 861
then added that initiates the release of stored Ca21. Given
that, by definition, the rates of Ca21 uptake and leak in
steady state are equal, the rate of [Ca21]er decrease upon
blockade of the SERCA must reflect the rate of Ca21 cy-
cling across the ER membrane and, thus, of the leak rate
at any given steady-state [Ca21]er. Fig. 3 B shows the rela-
tionship between [Ca21]er and leak rate, which can be fit-
ted by a power equation. In Bcl-2–overexpressing cells,
the data are more scattered, but for each [Ca21]er value,
the rate of Ca21 efflux is faster than in control cells. This
result is consistent with the evidence that Bcl-2 can induce
cation channels of low selectivity in artificial lipid bilayers
(Minn et al., 1997).
Previously, we have demonstrated that a reduction of
z30% in steady-state [Ca21]er results in a substantial acti-
vation (.50%) of the so-called capacitative Ca21 influx
(Hofer et al., 1998). The reduction in steady-state [Ca21]er
caused by Bcl-2 overexpression is thus expected to cause
an activation of this pathway. However, indirect evidence
(namely, the observation that the resting cytosolic Ca21
level is indistinguishable from controls) suggests that this
is not the case. To further investigate the problem, we
measured the capacitative Ca21 influx in Bcl-2–transfected
and control HeLa cells expressing cytAEQ (Fig. 4). The
cells were treated with the SERCA blocker (10 mM
tBuBHQ) while perfused with Ca21-free medium (KRB/
EGTA). This procedure first evoked a small transient in-
crease in [Ca21]c due to release of Ca21 from the stores.
When the release of stored Ca21 was complete (z3 min),
Ca21 was readded to the medium. This maneuver evoked a
second, larger [Ca21]c increase via the capacitative path-
way, which was markedly lower in Bcl-2–transfected than
in controls cells (1.19 6 0.11 in controls vs. 0.68 6 0.13 mM
in Bcl-2–expressing cells, n 5 6). The question then arises
as to the mechanism(s) through which Bcl-2 downregu-
lates capacitative Ca21 influx. Two possibilities were con-
sidered: one was that the reduction of this Ca21 influx
pathway is an adaptive mechanism to the long lasting re-
duction in steady-state [Ca21]er; the second was that the re-
duction is a direct consequence of Bcl-2 overexpression.
To distinguish between these two possibilities, we verified
whether a long-term reduction of [Ca21]er, obtained inde-
pendently of Bcl-2, could cause a comparable downregula-
tion of the capacitative Ca21 influx. Capacitative Ca21 in-
flux was thus compared in controls and in cells whose
[Ca21]er was reduced to values similar to those of Bcl-
2–overexpressing cells by prolonged incubation with a low
(100 mM) extracellular [Ca21]. In cells that had been main-
tained at low external [Ca21], and thus experienced a long-
term reduction in the resting [Ca21]er levels, the [Ca21]c
peak evoked by activation of the capacitative Ca21 influx
was markedly lower than in controls (0.59 6 0.11 mM, n 5
5). Of interest, the level of steady-state [Ca21]er in cells in-
cubated in low extracellular Ca21 was very similar (269 6
46 mM, n 5 4) to that measured in Bcl-2–overexpressing
cells incubated in normal (1 mM) extracellular Ca21 con-
centration. The simplest explanation of these results is that
the decrease in capacitative Ca21 influx is an adaptive
consequence to the prolonged reduction in steady-state
[Ca21]er, though, at the moment, it cannot be excluded that
other factors (e.g., a reduction in plasma membrane poten-
tial) contribute to this effect. This reduction in capacitative
Ca21 influx, on one hand, appears critical to maintain a
resting [Ca21]c indistinguishable from that of control cells,
despite a major reduction of [Ca21] in the ER; on the
other hand, it could account, at least in part, for a higher
resistance of cells expressing Bcl-2 to apoptotic cell death,
as the reduction of this ubiquitous Ca21 influx pathway
may prevent the overload of Ca21, considered one of the
key events in apoptosis. In agreement with this view, Ma
and coworkers recently demonstrated that SERCA over-
expression, by causing ER Ca21 overload, increases spon-
taneous apoptosis (Ma et al., 1999). Finally, our data are
not in contrast with previous results showing that the
SERCA inhibitor, thapsigargin, activates programed cell
death (Bian et al., 1997). In this latter case, in fact, the
Ca21 depletion is acute (1–2 min) and complete, whereas
in Bcl-2–transfected cells, the drop in [Ca21]er is modest
and develops slowly. Thus, thapsigargin not only causes a
massive activation of the capacitative Ca21 influx pathway,
but also such a drastic reduction in the level of [Ca21]er to
interfere with the basic activity of ER chaperonins.
We have demonstrated that overexpression of Bcl-2
causes a reduction of the steady-state [Ca21] levels, both in
the ER and in the Golgi apparatus, the two main agonist-
sensitive Ca21 stores. We also showed that this alteration
affects the Ca21 signal to which the effector systems are
exposed, in particular those located in local environments
highly dependent on the filling state of the intracellular
stores (such as the mitochondria). The chronic reduction
in [Ca21] of the ER results in a downregulation of the ca-
Figure 4. Capacitative Ca21 influx in control, Bcl-2–transfected,
and Ca21-deprived cells. A, Representitive trace. B, Average
[Ca21] peak. Parallel batches of HeLa cells were either cotrans-
fected with cytAEQ and Bcl-2 (Bcl-2), or transfected with
cytAEQ alone (control and Ca21-deprived). In the Ca21-deprived
cells, the cells were maintained in the 18 h preceding the experi-
ment in KRB containing a lower (0.1 mM) CaCl2 concentration
(KRB/lowCa21). After transferring the coverslip with the cells to
the luminometer chamber, the cells, perfused with KRB/EGTA,
were challenged with 10 mM tBuBHQ (a specific blocker of the
Ca21 ATPase present in the ER and Golgi apparatus) added to
the same medium. After 2 min, capacitative Ca21 entry was initi-
ated by changing the medium to KRB/Ca21 (CaCl2). All other
conditions as in Fig. 1. The Journal of Cell Biology, Volume 148, 2000 862
pacitative Ca21 influx. The alterations in Ca21 handling
provoked by Bcl-2 overexpression could be part of the
mechanisms through which Bcl-2 exerts its role in the con-
trol of cell growth. Targets of Bcl-2 effects on Ca21 ho-
meostasis could be: the ER itself, where sorting and traf-
ficking of proteins, e.g., enzymes or membrane receptors,
are modulated by luminal [Ca21] (Booth and Koch, 1989);
the mitochondria, where Ca21 accumulation regulates the
production of ATP (RobbGaspers et al., 1998; the concen-
tration of which is a key determinant of the apoptosis vs.
necrosis choice, Leist et al., 1997), and, possibly, the re-
lease of the apoptotic cofactor cytochrome c (Krajewski et
al., 1999); or the cytoplasm, where bulk or local [Ca21] in-
creases activate enzymatic effectors, such as the Ca21-
dependent protease, calpain (Carafoli and Molinari, 1998;
Squier et al., 1999), or the phosphatase, calcineurin (Wang
et al., 1999). Whether, and how, these routes interact, and
how they are affected by the alteration in Ca21 homeosta-
sis caused by Bcl-2, awaits further investigation.
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